A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine

Clinical trial NCT01516892 · COMPLETED

Trial details

NCT number: NCT01516892
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Migraine Disorders

Start date: 2011-12-01
Primary completion: 2015-11-01
Enrollment: 716

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.